Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype

MLA

Grazia Ambrosini, et al. “Impact of Combined MTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.” PLoS ONE, vol. 7, no. 7, Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cfbe5eced9092da916a87ed2736cfe25&authtype=sso&custid=ns315887.

APA

Grazia Ambrosini, Alan L. Ho, Gary K. Schwartz, Elgilda Musi, Elisa de Stanchina, Jayasree S. Nair, & Shyamprasad Deraje Vasudeva. (2012). Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. PLoS ONE, 7(7).

Chicago

Grazia Ambrosini, Alan L. Ho, Gary K. Schwartz, Elgilda Musi, Elisa de Stanchina, Jayasree S. Nair, and Shyamprasad Deraje Vasudeva. 2012. “Impact of Combined MTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.” PLoS ONE 7 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cfbe5eced9092da916a87ed2736cfe25&authtype=sso&custid=ns315887.